company-logoTuHURA Biosciences, Inc.$3.14
%
Analyst Rating: Hold

Stock Details

CEO

James A. Bianco

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

19

Address

10500 University Center Drive, Tampa

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Top Competitors

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for TuHURA Biosciences, Inc.  $3.14

$0

Min Forecast(+0% )

$249.61

Avg Forecast( +0% )

$325

Max Forecast(+0%)

EPS

Revenue

Institutional Holder

Loading institutional holder data...

Congress Tracker 

    Showing 0 of 0 results

    Insider Trading of Key Employees

      Showing 0 of 0 results

      Financial News: HURA